[Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital].
Nishikai, M · Nihon rinsho. Japanese journal of clinical medicine · 1992
Quick Summary
This study examined 51 patients with ME/CFS to look for physical and immune system clues about the illness. Researchers found that most patients had tender points similar to those seen in fibromyalgia, elevated antibodies to Epstein-Barr virus (a common virus), and lower numbers of certain immune cells called NK cells. These findings suggest that viral infections and immune system problems may play a role in ME/CFS.
Why It Matters
This study provides early evidence linking ME/CFS to specific immune abnormalities and past viral infection, supporting the biological basis of the illness rather than viewing it as purely psychological. Understanding these immune markers could eventually help with diagnosis and guide treatment approaches targeting viral or immune dysfunction.
Observed Findings
Elevated IgG antibody titers to Epstein-Barr virus capsid antigen in CFS patients compared to controls (p < 0.0015)
Tender points found in 49 of 51 patients, averaging 11.4 points per patient
Significantly lower mean numbers of NK cells (measured by CD57 marker) in CFS patients (p < 0.005)
NK cell activity was not significantly reduced in the patient group
No significant elevation of IgG antibody titers to HHV-6 in CFS patients
Inferred Conclusions
Viral infections, particularly Epstein-Barr virus, may be implicated in ME/CFS pathogenesis
Cellular immune dysfunction, specifically reduced NK cell populations, appears associated with ME/CFS
ME/CFS shares overlapping clinical features with fibromyalgia, as evidenced by widespread tender points
Both viral factors and immune system disorders may work together in ME/CFS development
Remaining Questions
Does Epstein-Barr virus reactivation cause or perpetuate ME/CFS, or is it simply a marker of immune dysregulation?
Why are NK cell numbers reduced while their activity remains relatively normal, and what is the functional significance?
What This Study Does Not Prove
This study does not prove that Epstein-Barr virus or reduced NK cells directly cause ME/CFS—only that these abnormalities are associated with the condition. The cross-sectional design cannot establish whether these immune changes are primary drivers of illness or secondary consequences. The study also does not explain why some people with similar immune markers develop ME/CFS while others do not.